Copyright
©The Author(s) 2024.
World J Virol. Sep 25, 2024; 13(3): 96453
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.96453
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.96453
Variables | Total recurrent stroke (AIS with prior stroke/TIA) | P value | ||
No COVID-19 (n = 95115), % | COVID-19 (n = 2140), % | |||
Age in years at admission | Median (IQR) | 72 (62-82) | 73 (63-82) | 0.001 |
18-44 | 3.6 | 3.7 | ||
45-64 | 27.0 | 23.4 | ||
≥ 65 | 69.4 | 72.9 | ||
Sex | Male | 51.0 | 53.5 | 0.023 |
Female | 49.0 | 46.5 | ||
Race | White | 68.9 | 53.2 | < 0.001 |
Black | 19.3 | 25.1 | ||
Hispanic | 8.6 | 17.2 | ||
Asian/Pacific Islander | 2.8 | 4.2 | ||
Native American | 0.4 | |||
Median household income national quartile for patient ZIP code | 0-25th | 31.3 | 36.5 | < 0.001 |
26-50th | 27.1 | 30.1 | ||
51-75th | 23.1 | 18.0 | ||
76-100th | 18.4 | 15.4 | ||
Payer type | Medicare | 72.8 | 74.6 | 0.118 |
Medicaid | 10.2 | 9.0 | ||
Private | 17.0 | 16.4 | ||
Hospital location & teaching status | Rural | 6.7 | 8.4 | 0.001 |
Urban Nonteaching | 18.6 | 16.6 | ||
Urban Teaching | 74.7 | 75.0 | ||
Hospital region | Northeast | 14.5 | 16.8 | < 0.001 |
Midwest | 21.1 | 19.2 | ||
South | 45.2 | 47.9 | ||
West | 19.2 | 16.1 | ||
Comorbidities | ||||
Hypertension | 89.5 | 85.7 | < 0.001 | |
Diabetes | 43.2 | 53.0 | < 0.001 | |
Hyperlipidemia | 66.8 | 61.4 | < 0.001 | |
Obesity | 14.9 | 16.1 | 0.124 | |
Peripheral vascular disease | 11.7 | 8.6 | < 0.001 | |
Tobacco use disorder | 28.9 | 28.3 | 0.535 | |
Prior MI | 10.3 | 5.8 | < 0.001 | |
Prior VTE | 5.6 | 6.3 | 0.162 | |
Cancer | 5.0 | 3.7 | 0.009 | |
Chronic kidney disease | 22.7 | 30.8 | < 0.001 | |
Alcohol abuse | 4.3 | 2.8 | 0.001 | |
Drug abuse | 3.1 | 2.1 | 0.007 | |
Depression | 11.8 | 9.6 | 0.001 | |
Chronic pulmonary disease | 17.3 | 15.0 | 0.004 | |
Hypothyroidism | 15.2 | 14.0 | 0.133 | |
Other thyroid disorders | 2.3 | 2.1 | 0.502 | |
Valvular disease | 2.7 | 1.6 | 0.002 | |
Autoimmune conditions | 3.2 | 2.8 | 0.283 | |
Outcomes | ||||
All-cause in-hospital mortality | 4.0 | 22.9 | < 0.001 | |
Disposition of patient | Routine | 36.6 | 25.2 | < 0.001 |
Transfer to short-term hospital | 2.8 | 3.4 | ||
Transfer other: SNF, ICF, etc. | 38.6 | 49.7 | ||
Home health care | 21.9 | 21.8 | ||
Length of stay (days) | Median (IQR) | 3 (2-6) | 7 (3-13) | < 0.001 |
Hospital charges (USD) | Median | $52662 | $80888 | < 0.001 |
In-hospital mortality | COVID-19 | Adjusted OR | 95%CI | P value | |
Lower Limit | Upper limit | ||||
Overall mortality | Yes vs No | 7.01 | 5.36 | 9.18 | < 0.001 |
In-hospital mortality by individual subgroup | |||||
Ages 45-64 | Yes vs No | 8.4 | 4.18 | 16.91 | < 0.001 |
Ages 65 and above | Yes vs No | 7.04 | 5.24 | 9.44 | < 0.001 |
Male | Yes vs No | 7.82 | 5.38 | 11.35 | < 0.001 |
Female | Yes vs No | 6.15 | 4.12 | 9.18 | < 0.001 |
Whites | Yes vs No | 5.54 | 3.79 | 8.09 | < 0.001 |
Blacks | Yes vs No | 5.73 | 3.08 | 10.68 | < 0.001 |
Hispanics | Yes vs No | 15.47 | 7.61 | 31.44 | < 0.001 |
Asian/Pacific Islanders | Yes vs No | 14.93 | 7.22 | 30.87 | < 0.001 |
- Citation: Desai R, Mellacheruvu SP, Akella SA, Mohammed AS, Hussain M, Mohammed AA, Saketha P, Sunkara P, Gummadi J, Ghantasala P. Recurrent stroke admissions with vs without COVID-19 and associated in-hospital mortality: A United States nationwide analysis, 2020. World J Virol 2024; 13(3): 96453
- URL: https://www.wjgnet.com/2220-3249/full/v13/i3/96453.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i3.96453